⌘K

Home/Filings/4/0001209191-21-069084

4//SEC Filing

Booth Andrew 4

Accession 0001209191-21-069084

CIK 0001703057other

View on SEC.gov Company Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 5:00 PM ET

Size

7.4 KB

Accession

0001209191-21-069084

Insider Transaction Report

Form 4

Period: 2021-12-10

AbCellera Biologics Inc.ABCL

Chief Financial Officer

Transactions

Exercise/Conversion
Common Shares
2021-12-10$0.32/sh+500,000$160,000→ 553,500 total
Exercise/Conversion
Share Options (right to buy)
2021-12-10−500,000→ 5,384,820 total
Exercise: $0.32From: 2020-03-23Exp: 2029-08-22→ Common Shares (500,000 underlying)

Holdings

Common Shares
(indirect: By Spouse)
130,959

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1

filerCIK 0001834411

Filing Metadata

Form type: 4
Filed: Dec 9, 7:00 PM ET
Accepted: Dec 10, 5:00 PM ET
Size: 7.4 KB

View on SEC.gov